These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 32250616)

  • 1. The Synthesizability of Molecules Proposed by Generative Models.
    Gao W; Coley CW
    J Chem Inf Model; 2020 Dec; 60(12):5714-5723. PubMed ID: 32250616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RetroGNN: Fast Estimation of Synthesizability for Virtual Screening and De Novo Design by Learning from Slow Retrosynthesis Software.
    Liu CH; Korablyov M; Jastrzębski S; Włodarczyk-Pruszyński P; Bengio Y; Segler M
    J Chem Inf Model; 2022 May; 62(10):2293-2300. PubMed ID: 35452226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Training recurrent neural networks as generative neural networks for molecular structures: how does it impact drug discovery?
    D'Souza S; Kv P; Balaji S
    Expert Opin Drug Discov; 2022 Oct; 17(10):1071-1079. PubMed ID: 36216812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of Deep Learning in Molecule Generation and Molecular Property Prediction.
    Walters WP; Barzilay R
    Acc Chem Res; 2021 Jan; 54(2):263-270. PubMed ID: 33370107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generative machine learning for de novo drug discovery: A systematic review.
    Martinelli DD
    Comput Biol Med; 2022 Jun; 145():105403. PubMed ID: 35339849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep learning for molecular generation.
    Xu Y; Lin K; Wang S; Wang L; Cai C; Song C; Lai L; Pei J
    Future Med Chem; 2019 Mar; 11(6):567-597. PubMed ID: 30698019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scaffold-Constrained Molecular Generation.
    Langevin M; Minoux H; Levesque M; Bianciotto M
    J Chem Inf Model; 2020 Dec; 60(12):5637-5646. PubMed ID: 33301333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The power of deep learning to ligand-based novel drug discovery.
    Baskin II
    Expert Opin Drug Discov; 2020 Jul; 15(7):755-764. PubMed ID: 32228116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parallel tempered genetic algorithm guided by deep neural networks for inverse molecular design.
    Nigam A; Pollice R; Aspuru-Guzik A
    Digit Discov; 2022 Aug; 1(4):390-404. PubMed ID: 36091415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial Intelligence-Enabled De Novo Design of Novel Compounds that Are Synthesizable.
    Bhisetti G; Fang C
    Methods Mol Biol; 2022; 2390():409-419. PubMed ID: 34731479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generative Deep Learning for Targeted Compound Design.
    Sousa T; Correia J; Pereira V; Rocha M
    J Chem Inf Model; 2021 Nov; 61(11):5343-5361. PubMed ID: 34699719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From Target to Drug: Generative Modeling for the Multimodal Structure-Based Ligand Design.
    Skalic M; Sabbadin D; Sattarov B; Sciabola S; De Fabritiis G
    Mol Pharm; 2019 Oct; 16(10):4282-4291. PubMed ID: 31437001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformer neural network for protein-specific de novo drug generation as a machine translation problem.
    Grechishnikova D
    Sci Rep; 2021 Jan; 11(1):321. PubMed ID: 33432013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevant Applications of Generative Adversarial Networks in Drug Design and Discovery: Molecular
    Lin E; Lin CH; Lane HY
    Molecules; 2020 Jul; 25(14):. PubMed ID: 32708785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GuacaMol: Benchmarking Models for de Novo Molecular Design.
    Brown N; Fiscato M; Segler MHS; Vaucher AC
    J Chem Inf Model; 2019 Mar; 59(3):1096-1108. PubMed ID: 30887799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo molecular design with deep molecular generative models for PPI inhibitors.
    Wang J; Chu Y; Mao J; Jeon HN; Jin H; Zeb A; Jang Y; Cho KH; Song T; No KT
    Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35830870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FSM-DDTR: End-to-end feedback strategy for multi-objective De Novo drug design using transformers.
    Monteiro NRC; Pereira TO; Machado ACD; Oliveira JL; Abbasi M; Arrais JP
    Comput Biol Med; 2023 Sep; 164():107285. PubMed ID: 37557054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep Reinforcement Learning for Multiparameter Optimization in
    Ståhl N; Falkman G; Karlsson A; Mathiason G; Boström J
    J Chem Inf Model; 2019 Jul; 59(7):3166-3176. PubMed ID: 31273995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graph-based generative models for de Novo drug design.
    Xia X; Hu J; Wang Y; Zhang L; Liu Z
    Drug Discov Today Technol; 2019 Dec; 32-33():45-53. PubMed ID: 33386094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ChemistGA: A Chemical Synthesizable Accessible Molecular Generation Algorithm for Real-World Drug Discovery.
    Wang J; Wang X; Sun H; Wang M; Zeng Y; Jiang D; Wu Z; Liu Z; Liao B; Yao X; Hsieh CY; Cao D; Chen X; Hou T
    J Med Chem; 2022 Sep; 65(18):12482-12496. PubMed ID: 36065998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.